Dikhloroskin en es it fr

Dikhloroskin Brand names, Dikhloroskin Analogs

Dikhloroskin Brand Names Mixture

  • No information avaliable

Dikhloroskin Chemical_Formula


Dikhloroskin RX_link


Dikhloroskin fda sheet

Dikhloroskin msds (material safety sheet)

Dikhloroskin MSDS

Dikhloroskin Synthesis Reference

No information avaliable

Dikhloroskin Molecular Weight

1749.82 g/mol

Dikhloroskin Melting Point

No information avaliable

Dikhloroskin H2O Solubility


Dikhloroskin State


Dikhloroskin LogP

No information avaliable

Dikhloroskin Dosage Forms

Vials containing colistimethate sodium or pentasodium colistinmethanesulfonate (150 mg colistin base activity) for injection.

Dikhloroskin Indication

For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.

Dikhloroskin Pharmacology

Colistimethate is a polymyxin antibiotic agent. Originally, colistimethate sodium was thought to be less toxic than polymyxin B; however, if the drugs are administered at comparable doses, their toxicities may be similar. Polymyxins are cationic polypeptides that disrupt the bacterial cell membrane through a detergentlike mechanism. With the development of less toxic agents, such as extended-spectrum penicillins and cephalosporins, parenteral polymyxin use was largely abandoned, except for the treatment of multidrug-resistant pulmonary infections in patients with cystic fibrosis. More recently, however, the emergence of multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, and the lack of new antimicrobial agents have led to the revived use of the polymyxins.

Dikhloroskin Absorption

Very poor absorption from gastrointestinal tract.

Dikhloroskin side effects and Toxicity

Oral LD50 in rats is 5450 mg/kg. Overdosage with colistimethate can cause neuromuscular blockade characterized by paresthesia, lethargy, confusion, dizziness, ataxia, nystagmus, disorders of speech and apnea. Respiratory muscle paralysis may lead to apnea, respiratory arrest and death.

Dikhloroskin Patient Information

Dikhloroskin Organisms Affected

Gram-negative bacilli